| Myung H Lee, MD | |
|
Lds Hospital, 8th Ave And C Street, Salt Lake City, UT 84143-0001 | |
| (801) 408-5060 | |
| Not Available |
| Full Name | Myung H Lee |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 19 Years |
| Location | Lds Hospital, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518121771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 7442439-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| A Step Forward Hospice | West haven, UT | Hospice |
| Intermountain Medical Center | Murray, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drops) in two important models of retinal neovascular disease, wet age-related macular degeneration (AMD) and ischemic retinopathy.
Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market.
According to the Australian Medical Association, the Federal Government is guilty of "policy inertia" when it comes to addressing the needs of aged care residents.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drops) in two important models of retinal neovascular disease, wet age-related macular degeneration (AMD) and ischemic retinopathy.
Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market.
According to the Australian Medical Association, the Federal Government is guilty of "policy inertia" when it comes to addressing the needs of aged care residents.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drops) in two important models of retinal neovascular disease, wet age-related macular degeneration (AMD) and ischemic retinopathy.
Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market.
According to the Australian Medical Association, the Federal Government is guilty of "policy inertia" when it comes to addressing the needs of aged care residents.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Myung H Lee, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 507-6990 | Myung H Lee, MD Lds Hospital, 8th Ave And C Street, Salt Lake City, UT 84143-0001 Ph: (801) 408-5060 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drops) in two important models of retinal neovascular disease, wet age-related macular degeneration (AMD) and ischemic retinopathy.
Neuroblastoma is one of the deadliest childhood cancers, accounting for 15 percent of pediatric cancer deaths. For patients with high-risk neuroblastomas, the five-year survival rate is 40 to 50 percent even with the most rigorous treatments available today.
A new study by researchers in the U.S. further supports the hypothesis that the unregulated release of inflammatory cytokines is responsible for the local and systemic inflammation that is associated with multi-organ damage and death in severe COVID-19.
Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market.
According to the Australian Medical Association, the Federal Government is guilty of "policy inertia" when it comes to addressing the needs of aged care residents.
› Verified 6 days ago
Jeffrey Von Miller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8 Th Ave And C St, Intermountain Hospitalist Group, Salt Lake City, UT 84143 Phone: 801-408-5482 Fax: 801-408-5481 | |
Dr. Roxanne J Weiss, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Dr. Erin L. Gosekamp, DO, MPH, MS Hospitalist Medicare: Medicare Enrolled Practice Location: 295 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-587-7572 | |
Rebecca Greaves Kim, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-2121 | |
Mr. Vijaykumar Lingegowda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 East 3900 S, Suite 4b, Salt Lake City, UT 84124 Phone: 866-500-7071 Fax: 866-500-7081 | |
Craig R. Goodall, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 30 N 1900 E Rm 4c116, Salt Lake City, UT 84132 Phone: 801-581-7606 | |
Dr. Prathima Ramaprasad, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 E 3900 S, South Salt Lake City, Salt Lake City, UT 84124 Phone: 801-809-0641 |